More specifically, in the STAD group, the expression of RCAN1, IL1A, ALDH3B1, EZH2, EPAS1, PXDN, UCP3, PDGFRB, COL1A1, DHFR, GPX1, AIFM1, JAK2, HYAL2, EDNRA, GCH1, and NOS3 increased, while the expression of NR4A3, CD36, MSRB3, SOD3, CRYAB, SNCA, APOD, BNIP3, SCARA3, GPX3, and PRKAA2 were decreased (Figure 1A, P < 0.05). This evidence concerns the gene IL1A and gastric adenocarcinoma.